Regional Citrate Anticoagulation in Pediatric Patients: Dealing with Practice Points
Blood Purification · 2025
DOI: 10.1159/000548786 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Blood Purification, 2025. Verfasst von Zaccaria Ricci und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency and Critical Care, Anesthesia and Pediatric Intensive Care Unit, Meyer Children's Hospital, IRCCS, Florence, Italy, zaccaria.…. Hauptthemen laut MEDLINE: Anticoagulants, Continuous Renal Replacement Therapy, Citric Acid, Citrates. Die Arbeit nennt 13 Literaturangaben.
Abstract (Originalsprache)
Background: Regional citrate anticoagulation (RCA) for continuous renal replacement therapy (CRRT) has been shown to be safe and effective both in adults and children. The equipment and the solutions available in the pediatric setting are the same as in adults. Summary: Currently three commercially available citrate formulations for RCA during continuous renal replacement therapy CRRT are present: concentrated (4% trisodium citrate, 136 mmol/L), semi-concentrated (anticoagulant dextrose-A, ACD-A, 75 mmol/L) and diluted (Prismocitrate/Regiocit, 18 mmol/L). RCA is delivered as a predilution infusion solution; therefore, its volume in dedicated commercially available citrate solutions impacts continuous renal replacement (CRRT) dose, filtration fraction, circuit pressures, and fluid flow. These aspects represent crucial details in the pediatric setting, and their relevance is more important as the smaller the patient’s body weight is. Thus, when RCA is prescribed in children, the blood pump flow rate, the dose, the load and the concentration of citrate, and the patient’s ability to metabolize citrate should be considered carefully and specifically contextualized by the citrate concentration available in each center. This technical review will describe these practice concepts that should be known in detail by the clinician approaching RCA in the pediatric setting. Key messages: Citrate “dose” is the citrate concentration in the blood running in the CRRT circuit. Citrate “load” represents the mass of citrate that is delivered to the circuit per each treatment hour. For a given citrate dose and blood flow rate, very different CRRT settings, sodium loads, filtration fractions, and dialytic doses are delivered by choosing the different formulations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency and Critical Care, Anesthesia and Pediatric Intensive Care Unit, Meyer Children's Hospital, IRCCS, Florence, Italy, zaccaria.ricci@unifi.it.
- Department of Health Science, Section of Anesthesia and Intensive Care, University of Florence, Florence, Italy, zaccaria.ricci@unifi.it.
- Paediatric Intensive Care, King's College Hospital, London, UK.
- Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Zitieren
APA
Ricci, Z., Deep, A., & Goldstein, S. L. (2025). Regional Citrate Anticoagulation in Pediatric Patients: Dealing with Practice Points. Blood Purification. https://doi.org/10.1159/000548786
Vancouver
Ricci Z, Deep A, Goldstein SL. Regional Citrate Anticoagulation in Pediatric Patients: Dealing with Practice Points. Blood Purification. 2025. doi:10.1159/000548786
BibTeX
@article{Ricci2025,
author = {Ricci, Zaccaria and Deep, Akash and Goldstein, Stuart L},
title = {Regional Citrate Anticoagulation in Pediatric Patients: Dealing with Practice Points},
journal = {Blood Purification},
year = {2025},
doi = {10.1159/000548786}
}
EUVIMED